Procter & Gamble reported $87.9B of revenue over the trailing twelve months, +3.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $87.9B (to Q1 2027). Net income: $16.0B, trailing twelve months to Q1 2027. Free cash flow: $15.3B, trailing twelve months to Q1 2027. Operating margin: 22%, trailing twelve months to Q1 2027.

PGProcter & Gamble

Consumer Defensive

$161.12+10% 1Y

$161.12

$136.0452 weeks$165.95

PG as reported

Procter & Gamble reported $87.9B of revenue over the trailing twelve months, +3.5% on the year before. 11 reported series are charted on this page, each one as filed.

$87.9B

Revenue, trailing twelve months · to Q1 2027 · +3.5% against the twelve months before

Net income: $16.0B
Net income · −4.4% year on year · trailing twelve months to Q1 2027
Free cash flow: $15.3B
Free cash flow · +2.7% year on year · trailing twelve months to Q1 2027
Operating margin: 22%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for PG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$87.9B	+3.5%	Q1 2027
Net income	$16.0B	−4.4%	Q1 2027
EPS	$6.64	−3.1%	Q1 2027
Gross margin	50%	n/a	Q1 2027
Operating margin	22%	n/a	Q1 2027
Net margin	18%	n/a	Q1 2027
ROE	30%	n/a	Q1 2027
ROA	13%	n/a	Q1 2027
ROIC	20%	n/a	Q1 2027
Free cash flow	$15.3B	+2.7%	Q1 2027
P/E	24.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.